. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology. 2002 Oct 22;59(8):1139-45. PubMed.


Please login to recommend the paper.


Make a Comment

To make a comment you must login or register.

Comments on this content

  1. Equivocal data but intriguing nonetheless. Maybe another evidence for Aβ clearance as therapeutic for amyloid pathology/clinical outcome. Hard to know though whether this is persuasive enough to mount a sufficiently powered trial and blinded perhaps?

This paper appears in the following:


  1. Siphoning off the Toxic Humors: CSF Shunts in AD